#152534

Anti-ADAM19 [19MOCYT]

Cat. #152534

Anti-ADAM19 [19MOCYT]

Cat. #: 152534

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: ADAM19

Class: Polyclonal

Application: WB

Reactivity: Mouse

Host: Rabbit

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Carl Blobel

Institute: Hospital for Special Surgery

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-ADAM19 [19MOCYT]
  • Clone: 19MOCYT
  • Tool sub type: Primary antibody
  • Class: Polyclonal
  • Conjugation: Unconjugated
  • Molecular weight: ~120 kDa
  • Reactivity: Mouse
  • Host: Rabbit
  • Application: WB
  • Description: ADAM19, is a member of the ADAM (a disintegrin and metalloprotease-like domain) family. It has been cloned from mouse and human. ADAM19 was first described in muscle cells as a protein with homology to the fertilins (ADAMs 1 and 2). Initial observations indicated a role for ADAM19 in myoblast fusion, similar to sperm-egg fusion aided by ADAMs 1 and 2. Later works describe ADAM19 in the bone, muscle, lung, heart, brain, kidney, and a wide range of tissues. Also reported is a sequence of ADAM19 lacking the transmembrane and cytoplasmic domains, suggesting that a soluble form is produced. Other ADAMs family members (ADAM-10, ADAM-17) have been more thoroughly studied, and are known to play key roles in inflammation, growth factor maturation and release, and a wide range of other functions.
  • Immunogen: GST-fusion protein with the cytoplasmic domain of murine ADAM19

Target Details

  • Target: ADAM19
  • Molecular weight: ~120 kDa
  • Target background: ADAM19, is a member of the ADAM (a disintegrin and metalloprotease-like domain) family. It has been cloned from mouse and human. ADAM19 was first described in muscle cells as a protein with homology to the fertilins (ADAMs 1 and 2). Initial observations indicated a role for ADAM19 in myoblast fusion, similar to sperm-egg fusion aided by ADAMs 1 and 2. Later works describe ADAM19 in the bone, muscle, lung, heart, brain, kidney, and a wide range of tissues. Also reported is a sequence of ADAM19 lacking the transmembrane and cytoplasmic domains, suggesting that a soluble form is produced. Other ADAMs family members (ADAM-10, ADAM-17) have been more thoroughly studied, and are known to play key roles in inflammation, growth factor maturation and release, and a wide range of other functions.

Applications

  • Application: WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: Whole serum
  • Storage conditions: -20° C
  • Shipping conditions: Shipping at 4° C

References

  • Chesneau et al. 2003. J Biol Chem. 278(25):22331-40. PMID: 12682046.
  • Inoue et al. 1998. J Biol Chem. 273(7):4180-7. PMID: 9461614.
  • Kawaguchi et al. 2007. J Cell Sci. 120(Pt 6):943-52. PMID: 17344430.
  • Zhou et al. 2004. Mol Cell Biol. 24(1):96-104. PMID: 14673146.